Docetaxel-loaded solid lipid nanoparticles suppress breast cancer cells growth with reduced myelosuppression toxicity

References

• Gueritte-VoegeleinFGuenardDDuboisJWahlAPotierPChemical and biological studies on Taxol (paclitaxel) and Taxotere (docetaxel), new antineoplastic agentsJ Pharm Belg1994493193205 French7914532
   PubMedGoogle Scholar
• MonteroAFossellaFHortobagyiGValeroVDocetaxel for treatment of solid tumours: a systematic review of clinical dataLancet Oncol20056422923915811618
   PubMed Web of Science ®Google Scholar
• SaloustrosEGeorgouliasVDocetaxel in the treatment of advanced non-small-cell lung cancerExpert Rev Anticancer Ther2008881207122218699760
   PubMed Web of Science ®Google Scholar
• SaloustrosEMavroudisDGeorgouliasVPaclitaxel and docetaxel in the treatment of breast cancerExpert Opin Pharmacother20089152603261618803448
   PubMed Web of Science ®Google Scholar
• AaproMThe scientific rationale for developing taxoidsAnticancer Drugs19967Suppl 233368862709
   PubMed Web of Science ®Google Scholar
• CanalesARodriguez-SalarichsJTrigiliCInsights into the interaction of discodermolide and docetaxel with tubulin. Mapping the binding sites of microtubule-stabilizing agents by using an integrated NMR and computational approachACS Chem Biol20116878979921539341
   PubMed Web of Science ®Google Scholar
• Hernandez-VargasHPalaciosJMoreno-BuenoGMolecular profiling of docetaxel cytotoxicity in breast cancer cells: uncoupling of aberrant mitosis and apoptosisOncogene200726202902291317099726
   PubMed Web of Science ®Google Scholar
• BerchemGJBosselerMMineNAvalosseBNanomolar range docetaxel treatment sensitizes MCF-7 cells to chemotherapy induced apoptosis, induces G2M arrest, and phosphorylates bcl-2Anticancer Res1999191A53554010226594
   PubMed Web of Science ®Google Scholar
• KuppensIECurrent state of the art of new tubulin inhibitors in the clinicCurr Clin Pharmacol200611577018666378
   PubMedGoogle Scholar
• BakerJAjaniJScotteFDocetaxel-related side effects and their managementEur J Oncol Nurs2009131495919201649
   PubMed Web of Science ®Google Scholar
• KatsumataNDocetaxel: an alternative taxane in ovarian cancerBr J Cancer200389Suppl 3S9S1514661041
   PubMedGoogle Scholar
• HennenfentKLGovindanRNovel formulations of taxanes: a review. Old wine in a new bottle?Ann Oncol200617573574916364960
   PubMed Web of Science ®Google Scholar
• WeiszharZCzuczJReveszCRosivallLSzebeniJRozsnyayZComplement activation by polyethoxylated pharmaceutical surfactants: Cremophor-EL, Tween-80, and Tween-20Eur J Pharm Sci201245449249821963457
   PubMed Web of Science ®Google Scholar
• KarveSWernerMESukumarRRevival of the abandoned therapeutic wortmannin by nanoparticle drug deliveryProc Natl Acad Sci U S A2012109218230823522547809
   PubMed Web of Science ®Google Scholar
• HwangHYKimISKwonICKimYHTumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticlesJ Control Release20081281233118374444
   PubMed Web of Science ®Google Scholar
• XuZChenLGuWThe performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinomaBiomaterials200930222623218851881
   PubMed Web of Science ®Google Scholar
• EsmaeiliFDinarvandRGhahremaniMHOstadSNEsmailyHAtyabiFCellular cytotoxicity and in-vivo biodistribution of docetaxel poly(lactide-co-glycolide) nanoparticlesAnticancer Drugs2010211435219809300
   PubMed Web of Science ®Google Scholar
• YanasarnNSloatBRCuiZNanoparticles engineered from lecithin-in-water emulsions as a potential delivery system for docetaxelInt J Pharm2009379117418019524029
   PubMed Web of Science ®Google Scholar
• ImmordinoMLBrusaPArpiccoSStellaBDosioFCattelLPreparation, characterization, cytotoxicity, and pharmacokinetics of liposomes containing docetaxelJ Control Release200391341742912932719
   PubMed Web of Science ®Google Scholar
• LiangGJia-BiZFeiXBinNPreparation, characterization, and pharmacokinetics of N-palmitoyl chitosan anchored docetaxel liposomesJ Pharm Pharmacol200759566166717524231
   PubMed Web of Science ®Google Scholar
• ZhaiGWuJXiangGPreparation, characterization, and pharmacokinetics of folate receptor-targeted liposomes for docetaxel deliveryJ Nanosci Nanotechnol2009932155216119435095
   PubMed Web of Science ®Google Scholar
• WernerMECoppJAKarveSFolate-targeted polymeric nanoparticle formulation of docetaxel is an effective molecularly targeted radiosensitizer with efficacy dependent on the timing of radiotherapyACS Nano20115118990899822011071
   PubMed Web of Science ®Google Scholar
• ElsabahyMPerronMEBertrandNYuGELerouxJCSolubilization of docetaxel in poly(ethylene oxide)-block-poly(butylene/styrene oxide) micellesBiomacromolecules2007872250225717579476
   PubMed Web of Science ®Google Scholar
• ShinHCAlaniAWRaoDARockichNCKwonGSMulti-drug loaded polymeric micelles for simultaneous delivery of poorly soluble anticancer drugsJ Control Release2009140329430019409432
   PubMed Web of Science ®Google Scholar
• MuCFBalakrishnanPCuiFDThe effects of mixed MPEG-PLA/Pluronic copolymer micelles on the bioavailability and multidrug resistance of docetaxelBiomaterials20103182371237920031202
   PubMed Web of Science ®Google Scholar
• LiuJZahediPZengFAllenCNano-sized assemblies of a PEG-docetaxel conjugate as a formulation strategy for docetaxelJ Pharm Sci20089783274329018064681
   PubMed Web of Science ®Google Scholar
• FarokhzadOCChengJTeplyBATargeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivoProc Natl Acad Sci U S A2006103166315632016606824
   PubMed Web of Science ®Google Scholar
• ZhengDLiDLuXFengZEnhanced antitumor efficiency of docetaxel-loaded nanoparticles in a human ovarian xenograft model with lower systemic toxicities by intratumoral deliveryOncol Rep201023371772420127011
   PubMed Web of Science ®Google Scholar
• GaoYYangRZhangZChenLSunZLiYSolid lipid nanoparticles reduce systemic toxicity of docetaxel: performance and mechanism in animalNanotoxicology20115463664921306192
   PubMed Web of Science ®Google Scholar
• ZhangPChenLZhangZLinLLiYPharmacokinetics in rats and efficacy in murine ovarian cancer model for solid lipid nanoparticles loading docetaxelJ Nanosci Nanotechnol201010117541754421137978
   PubMed Web of Science ®Google Scholar
• JemalABrayFCenterMMFerlayJWardEFormanDGlobal cancer statisticsCA Cancer J Clin2011612699021296855
   PubMed Web of Science ®Google Scholar
• FerlayJShinHRBrayFFormanDMathersCParkinDMEstimates of worldwide burden of cancer in 2008: GLOBOCAN 2008Int J Cancer2010127122893291721351269
   PubMed Web of Science ®Google Scholar
• CrownJO’LearyMOoiWSDocetaxel and paclitaxel in the treatment of breast cancer: a review of clinical experienceOncologist20049Suppl 2243215161988
   PubMed Web of Science ®Google Scholar
• SandbergRLarssonOImproved precision and accuracy for microarrays using updated probe set definitionsBMC Bioinformatics200784817288599
   PubMed Web of Science ®Google Scholar
• SmythGKLinear models and empirical Bayes methods for assessing differential expression in microarray experimentsStat Appl Genet Mol Biol20043 Article3
   PubMedGoogle Scholar
• DennisGJrShermanBTHosackDADAVID: Database for Annotation, Visualization, and Integrated DiscoveryGenome Biol200345P312734009
   PubMed Web of Science ®Google Scholar
• KongLYuanQZhuHThe suppression of prostate LNCaP cancer cells growth by selenium nanoparticles through Akt/Mdm2/AR controlled apoptosisBiomaterials201132276515652221640377
   PubMed Web of Science ®Google Scholar
• SongHVitaMSallamHEffect of the Cdk-inhibitor roscovitine on mouse hematopoietic progenitors in vivo and in vitroCancer Chemother Pharmacol200760684184917318617
   PubMed Web of Science ®Google Scholar
• PuriALoomisKSmithBLipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinicCrit Rev Ther Drug Carrier Syst200926652358020402623
   PubMed Web of Science ®Google Scholar